文献速递牙体牙髓病

根管内药物的现状与未来方向

Present status and future directions of intracanal medicaments.
PubMed 文献 · Int Endod J · 2022-04-19

本文为叙述性综述,聚焦根管内药物的现状、临床使用指征与未来研究方向。根管治疗预后受术中因素、宿主与微生物因素及全身疾病等多变量影响,临床医生需综合分析这些变量并纳入消毒策略以最大化愈合机会。

要点

  • 根管治疗预后受术中因素、宿主与微生物因素及全身疾病等多变量影响。
  • 临床医生需综合分析各变量并纳入消毒策略以最大化愈合机会。
  • 本文将聚焦根管内药物的现状、临床使用指征与未来研究方向。

核心结论

  • 根管治疗预后受术中因素、宿主与微生物因素以及多种医学状况影响,临床医生应分析这些变量并纳入消毒策略以最大化愈合机会。

研究设计与样本

  • 叙述性综述,聚焦根管内药物的现状、临床使用指征与未来研究方向。

主要发现

  • 影响根管治疗预后的术中因素包括冲洗技术、根尖预备尺寸、根管内药物的使用或完成治疗所需的就诊次数。
  • 宿主与微生物因素包括根周骨丧失或组织损伤的强度、术前疼痛及机械性异常性疼痛和中枢敏化等相关状况、根尖区解剖复杂性以及细菌感染的毒力和存留时间。
  • 多种医学状况被报道会降低免疫系统愈合根尖周组织的能力。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Two fundamental goals of endodontic treatment are to prevent or treat apical periodontitis. From a predictive perspective, several variables can affect the outcome of root canal treatment. Some of these variables depend on intraoperative factors, which include irrigation technique, size of the apical preparation, use of intracanal medicaments or the number of appointments necessary to complete the treatment. However, the outcome may also be affected by host and microbial factors. The intensity of periradicular bone loss or tissue damage, the presence of preoperative pain and associated conditions such as mechanical allodynia and central sensitization, the anatomical complexity of the apical portion of the canal, and the virulence and longevity of the bacterial infection can all have a profound influence on the outcome. Furthermore, numerous medical conditions have been reported to decrease the capability of the immune system to heal the periapical tissues. It is the clinician's responsibility to analyse these variables and incorporate them into the disinfection strategy to maximize the chances of healing. This narrative review will focus on the present status of intracanal medicaments, the clinical indications for their use and future directions for research.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Ordinola-Zapata R, Noblett WC, Perez-Ron A, et al. Present status and future directions of intracanal medicaments. Int Endod J. 2022. PMID: 35322427. doi:10.1111/iej.13731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。